Drug that helps increase the survival rate by 30% after cervical cancer diagnosis
Scientists Conduct Phase Three Clinical Trials for Cervical Cancer Treatment Drugs, Potentially Increasing Survival Rates by 30%.The drug, known as TIVDAK (tisotumab vedotin), is administered via intravenous injection. The response ...
